Keyphrases
Protein Kinase B
100%
Biological Evaluation
100%
AKT Inhibitor
100%
Synthetic Evaluation
100%
HeLa Cells
66%
Antiviral Activity
66%
Mycobacterium Fortuitum
66%
Parainfluenza Virus 5
66%
Cancer Cells
33%
Anticancer Activity
33%
Antiviral Agents
33%
Anticancer Agents
33%
Cell Viability
33%
Cytotoxicity
33%
Phosphoinositide 3-kinase (PI3K)
33%
Host Cell Proteins
33%
Intracellular Bacteria
33%
Recombinant
33%
Biological Activity
33%
Cancer Cell Lines
33%
Carcinoma Cells
33%
Low Toxicity
33%
Ethyl
33%
HeLa
33%
Normal Cell Line
33%
Cyclization
33%
Unsaturated Aldehyde
33%
Route-based
33%
Six-step
33%
Dodecyl
33%
NHBE Cells
33%
Benzimidazole
33%
Benzimidazole Derivatives
33%
Protein Kinase B Pathway
33%
Bioactive Scaffolds
33%
Arylenediamine
33%
ZrCl4
33%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Antiviral Activity
100%
Protein Kinase B Inhibitor
100%
Parainfluenza Virus 5
100%
Anticarcinogen
50%
Antivirus Agent
50%
Normal Human
50%
Cell Viability
50%
Phosphatidylinositol 3 Kinase
50%
Biological Activity
50%
Protein Kinase B
50%
Intracellular Bacterium
50%
Carcinoma
50%
Benzimidazole
50%
Benzimidazole Derivative
50%
Mycobacterium fortuitum
50%
Cytotoxicity
50%
Aldehyde
50%
Medicine and Dentistry
Antiviral Activity
100%
Protein Kinase B Inhibitor
100%
Parainfluenza Virus 5
100%
Cancer Cell
50%
Anticarcinogen
50%
Antivirus Agent
50%
Cell Viability
50%
Cytotoxicity
50%
Phosphoinositide 3-Kinase
50%
Antineoplastic Activity
50%
Protein Kinase B
50%
Biological Activity
50%
Carcinoma Cell
50%
Cancer Cell Line
50%
Mycobacterium fortuitum
50%
Benzimidazole Derivative
50%
Benzimidazole
50%
Aldehyde
50%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Protein Kinase B
100%
Antiviral Activity
100%
Parainfluenza Virus 5
100%
Anticancer
50%
Cytotoxicity
50%
Antineoplastic Activity
50%
Phosphoinositide 3-Kinase
50%
Biological Activity
50%
Normal Human
50%
Intracellular Bacterium
50%
Cell Viability
50%
Mycobacterium fortuitum
50%